Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The 6-month BPaL(M) Regimen for the Treatment of Patients With MDR/RR-TB: Multicenter, Single-arm, Operational Research, Clinical Trial

NCT05381194 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT05381194
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05381194 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The 6-month BPaL(M) Regimen for the Treatment of Patients With MDR/RR-TB: Multicenter, Single-arm, Operational Research, Clinical Trial
Lead sponsor
Asan Medical Center
Phase
Phase 4
Overall status
Recruiting
Start date
December 13, 2022
Completion date
December 31, 2027
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multidrug- and rifampicin-resistant tuberculosis